Invest now in myomo, inc.

Please fill in this form to indicate your desired investment amount.

Thank you! Your submission has been received!
Step 2: Open an Account

Please select from one of the following options:


For US Investors:

Open BANQ Account

Or

Complete Via Escrow

EXISTING BANQ CUSTOMERS:
LOGIN TO BANQ client PORTAL
Oops! Something went wrong while submitting the form
overview
Offering details
DocumentATion
Upcoming
LIVE

DERMAdoctor, Inc.

Consumer Products
I
NASDAQ: DDOC

This is a firm commitment initial public offering of 1,875,000 shares of common stock to be priced between $7.00 - $9.00 per share

DERMAdoctor is an omni-channel, innovative, skincare company primarily focused on the creation of products that are designed to target common skin concerns, ranging from aging and blemishes to dry skin, perspiration and keratosis pilaris. They develop, market, distribute and sell skincare products under their DERMAdoctor® brand worldwide. All of their DERMAdoctor® products are conceived by their product design team headed by their Chief Creative Officer and founder, Dr. Audrey Kunin, who is a board-certified dermatologist. Dr. Kunin adds her unique perspective, which is incorporated in their packaging, that skincare can be both elegant and powerful. Their philosophy is to mix science and technology synergistically to provide non-irritating, effective and pleasing skincare products aimed at targeting overlooked or unfulfilled common skin concerns. All of their products are fragrance and dye free. Since 2003, they have been developing, marketing, distributing and selling an extensive array of their proprietary skincare products. Today, they produce and sell over 30 DERMAdoctor® products that account for 39 stock keeping units, or skus, at prices ranging from $22 for an antiperspirant to $95 for a Kakadu vitamin C skin product. Their products are typically grouped into families of products and include those such as Wrinkle Revenge, Ain’t Misbehavin’, Calm Cool and Corrected and KP Duty designed to improve the skin’s appearance for aging, acne, redness and keratosis pilaris, respectively. Within each family, products are typically further broken down to face, eyes, and body. The ingredients are then uniquely formulated for the resulting product subcategory. Each family of products creates opportunities for the customer to expand into different product types aimed at addressing their particular skincare problems. For example, within their KP Duty family they offer both a lotion and a scrub. Often these products are purchased together. They recently launched a third KP Duty product, the KP Duty Body Peel, providing an innovative product delivery system which should expand this family of products to a large group of current customer users.

 

expected offering size
$
15,000,000
Valuation
$
EXPECTED OFFERING Price
$
ANTICIPATED EXCHANGE
NASDAQ
INDicate now

Please fill in this form to indicate your desired investment amount and receive updates on the offering.

INDICATION RECEIVED

Thank you for submitting your Indication of Interest for the upcoming IPO. A confirmation email has been sent to you. The offering is not currently live for investment, however we encourage U.S. Citizens to open and fund an account with BANQ® to participate in the offering. International investors will be able to participate once the offering is qualified using our escrow function.

U.S. Citizens, please click below to complete the process.

OPEN ACCOUNT

Please fill in this form to indicate your desired investment amount.

Thank you for your indication for the upcoming IPO. 

The offering is not currently live for investment, however we encourage you to open and fund an account to reserve your indication.

Please click below to complete the process.
OPEN ACCOUNT
Oops! Something went wrong while submitting the form

Please fill in this form to indicate your desired investment amount.

Thank you for your indication for the upcoming IPO. 

The offering is not currently live for investment, however we encourage you to open and fund an account to reserve your indication.

Please click below to complete the process.
OPEN ACCOUNT
Oops! Something went wrong while submitting the form
Oops! Something went wrong while submitting the form. Please correct your entry.

Please fill in this form to indicate your desired investment amount and receive updates on the offering.

INDICATION RECEIVED

Thank you for submitting your Indication of Interest for the upcoming IPO. A confirmation email has been sent to you. The offering is not currently live for investment, however we encourage U.S. Citizens to open and fund an account with BANQ® to participate in the offering. International investors will be able to participate once the offering is qualified using our escrow function.

U.S. Citizens, please click below to complete the process.

OPEN ACCOUNT

Please fill in this form to indicate your desired investment amount.

Thank you for your indication for the upcoming IPO. 

The offering is not currently live for investment, however we encourage you to open and fund an account to reserve your indication.

Please click below to complete the process.
OPEN ACCOUNT
Oops! Something went wrong while submitting the form

Please fill in this form to indicate your desired investment amount.

Thank you for your indication for the upcoming IPO. 

The offering is not currently live for investment, however we encourage you to open and fund an account to reserve your indication.

Please click below to complete the process.
OPEN ACCOUNT
Oops! Something went wrong while submitting the form
Oops! Something went wrong while submitting the form. Please correct your entry.
user Stories
 
 
 
The Offering

Offering Highlights

Please see Prospectus for full offering details, risk factors and terms of the offering below or at the following link: https://www.sec.gov/Archives/edgar/data/1664180/000121390018005438/fs12018_dermadoctor.htm

BANQ is participating as a best efforts syndicate member in the DERMAdoctor, Inc. offering. Please note that some offerings have high demand, which lessens the availability of shares to allocate to BANQ customers. Allocations are not guaranteed. Our goal is to fairly distribute shares across all public participants and level the playing field. If you did not receive an allocation, it may be for the following reasons: 

  • ‍Not enough cash to cover the purchase 
  • Duplicate orders 
  • Multiple accounts: be sure to indicate for the correct account 
  • Fractional or incorrect amounts indicated 

Please be sure to properly place your indication of interest.

Please further note that if you indicate interest you will be notified after pricing and effectiveness the final terms. You must affirmatively reconfirm any prior indications or offers made prior to such effectiveness or your order will not be accepted. 

OFFERING Documentation

Legal Disclaimer

This is a firm commitment initial public offering of 1,875,000 shares of common stock of DERMAdoctor, Inc. No public market currently exists for DERMAdoctro shares. They anticipate that the initial public offering price will be between $7.00 and $9.00 per share. Prior to this offering, there has been no public market for our common stock. They have applied to list their shares of common stock for trading on the Nasdaq Capital Market (“Nasdaq”) under the symbol “DDOC.” No assurance can be given that their application will be approved. Investing in their common stock involves a high degree of risk. See “Risk Factors” beginning on page 12 of the prospectus for a discussion of information that you should consider before investing in their securities. A registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. No offer to buy the securities can be accepted and no part of the purchase price can be received until the registration statement has become effective, and any such offer my withdrawn or revoked, without obligation or commitment of any kind, at any time prior to notice of its acceptance given after the effective date. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, we will arrange to send you the preliminary prospectus if you contact ThinkEquity, a division of Fordham Financial Management, Inc., Prospectus Department, 17 State Street, 22nd Floor, New York, NY 10004, telephone: 646 968 9355 or e-mail: prospectus@think-equity.com . The information in the preliminary prospectus is not complete and may be changed. This preliminary prospectus is not an offer to sell these securities and we are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

Contact Form

Have Questions? Want to speak to a broker? Call (917) 512-0825 or fill out the Contact Form below:

TICKER SYMBOL:
NASDAQ: DDOC
Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form